Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

NACompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2002

Study Completion Date

October 31, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

FOLFOX regimen

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (19)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

19111

Fox Chase Cancer Center, Philadelphia

20852

Cancer Therapy Evaluation Program, Bethesda

30342

Atlanta Cancer Care, Atlanta

32224

Mayo Clinic, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

67214

Cancer Center of Kansas - Wichita, Wichita

70112

Louisiana State University School of Medicine, New Orleans

84112

Huntsman Cancer Institute, Salt Lake City

85259

Mayo Clinic Scottsdale, Scottsdale

89106

Southern Nevada Cancer Research Foundation, Las Vegas

98101

Virginia Mason Medical Center, Seattle

99508

Anchorage Oncology Centre, Anchorage

92093-0658

University of California San Diego Cancer Center, La Jolla

06520-8028

Yale Comprehensive Cancer Center, New Haven

59107-5200

St. Vincent Hospital and Health Center, Billings

08903

Cancer Institute of New Jersey, New Brunswick

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00039611 - Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter